Founded in Tokyo in 1998, Global Brain is a venture capital firm focusing on seed to late-stage investments across various sectors globally. They have invested in over 300 startups, facilitating 25 IPOs and 61 M&As through hands-on support services.
Investment Group Partner and Fellow Chief of Space Lab
Tatsunori Arai
Director
Megumi Asatsuma
Director
Anjani Bansal
Partner / India Office Representative
Past deals in Pets
RABO
Venture Round in 2024
RABO, Inc. is a Japan-based company specializing in the development of Internet of Things (IoT) collar-type wearable devices aimed at monitoring the behavior and health of cats. Founded in 2018 and headquartered in Shibuya, RABO designs and manufactures products such as the Catlog pendant and belt, which continuously tracks cats' activity data for health management purposes. The company also offers the Catlog home and a mobile application, allowing cat owners to review their pets' activity and health metrics, including weight and urine volume. RABO distributes its products primarily through online retail channels, catering to the growing demand for pet technology solutions that enhance the well-being of cats.
Poppy AI
Seed Round in 2023
Poppy AI is an agency that creates pet emojis and designs them to be visually appealing. The company's product focuses on emotional wellness, offering a group journaling app called "Waffle." It allows users to share journals with close friends and family, providing a psychologically safe space for mutual support.
FidoCure
Venture Round in 2022
FidoCure develops AI-driven precision medicine for canine cancer. It analyzes data from naturally occurring canine tumors using next-generation sequencing and clinical information to build a proprietary learning database for cancer analysis. The company provides genomic sequencing services and targeted therapy recommendations to veterinarians, enabling personalized treatment plans. By linking veterinary and human oncology, FidoCure advances comparative oncology, aims to improve outcomes for dogs and to inform drug development that benefits both pets and people.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.